Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-010046
Filing Date
2025-12-10
Accepted
2025-12-10 16:03:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4418
  Complete submission text file 0001950047-25-010046.txt   5908
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address
HERSHBERG ROBERT (Reporting) CIK: 0001274139 (see all company filings)

Type: 144

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38957 | Film No.: 251561958
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)